Remain on track to initiate registrational THRIVE-3 trial in 1Q' 2025 NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transfo ...
Letter of Intent Signed with Lotus Energy Recycling for Canadian Joint VentureTo Collaborate on Recycling End-of-Life Photovoltaic (PV) Cells and Solar Panels in North America Focus on Recovering Valu ...
Christmas symbols we all know and love. N othing says “Christmas” like the sights, smells and sounds of the season: From ...